These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7026083)

  • 1. Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
    Romson JL; Haack DW; Abrams GD; Lucchesi BR
    Circulation; 1981 Nov; 64(5):906-14. PubMed ID: 7026083
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pulmonary embolism with prostacyclin.
    Utsunomiya T; Krausz MM; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1980 Jul; 88(1):25-30. PubMed ID: 6992319
    [No Abstract]   [Full Text] [Related]  

  • 4. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary and systemic haemodynamic effects of prostaglandins in the unanaesthetized dog.
    Bloor CM; White FC; Sobel BE
    Cardiovasc Res; 1973 Mar; 7(2):156-66. PubMed ID: 4694100
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation.
    Aiken JW; Gorman RR; Shebuski RJ
    Prostaglandins; 1979 Apr; 17(4):483-94. PubMed ID: 111306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
    Fiedler VB; Mardin M
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
    Fuster V; Chesebro JH
    Mayo Clin Proc; 1981 Mar; 56(3):185-95. PubMed ID: 7010003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris.
    Ganz P; Gaspar J; Colucci WS; Barry WH; Mudge GH; Alexander RW
    Am J Cardiol; 1984 Jun; 53(11):1500-4. PubMed ID: 6375336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog.
    Shebuski RJ; Aiken JW
    J Cardiovasc Pharmacol; 1980; 2(5):667-77. PubMed ID: 6157958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig.
    van der Giessen WJ; Mooi WJ; Rutteman AM; Berk L; Verdouw PD
    Thromb Res; 1984 Oct; 36(1):45-51. PubMed ID: 6209820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
    Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
    Lefer AM; Ogletree ML; Smith JB; Silver MJ; Nicolaou KC; Barnette WE; Gasic GP
    Science; 1978 Apr; 200(4337):52-4. PubMed ID: 345441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
    Hossman V; Heinen A; Auel H; FitzGerald GA
    Thromb Res; 1981 May; 22(4):481-90. PubMed ID: 7027528
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary and systemic hemodynamic effects of diazepam (Valium) in the unanesthetized dog.
    Bloor CM; Leon AS; Walker DE
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1043-51. PubMed ID: 4760879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.